US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Liquidia Corporation - Common Stock (NQ:LQDA)

28.64 +0.65 (+2.32%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Liquidia Corporation - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest. 
Via Benzinga
News headline image
U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation
From Liquidia Corporation
Via GlobeNewswire
News headline image
Where Liquidia Stands With Analysts ↗
 
Via Benzinga
News headline image
Liquidia: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Outlook For Liquidia ↗
 
Via Benzinga
News headline image
Where Liquidia Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Needham Maintains Buy Rating for Liquidia: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Liquidia Technologies's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke. ↗
These seven high-risk stocks could ultimately rocket to the moon, or fall to the depths of the stock market graveyard. 
Via InvestorPlace
News headline image
Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at BofA Securities 2023 Health Care Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications
From Liquidia Corporation
Via GlobeNewswire
News headline image
NVIDIA To Rally Around 19%? Here Are 10 Other Analyst Forecasts For Friday ↗
Wells Fargo raised the price target for Warner Bros. Discovery, Inc. (NASDAQ: WBD) from $13 to $20. Wells Fargo analyst Steven Cahall upgraded the stock from Equal-Weight to Overweight. Warner Bros.... 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Liquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
From Liquidia Corporation
Via GlobeNewswire
News headline image
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Company to host webcast and conference call today at 8:30 a.m. ET 
From Liquidia Corporation
Via GlobeNewswire
News headline image
Earnings Outlook For Liquidia Technologies ↗
Liquidia Technologies (NASDAQ:LQDA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >